Detalhe da pesquisa
1.
Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine.
J Infect Dis
; 228(8): 999-1011, 2023 10 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37079393
2.
One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines.
J Infect Dis
; 227(10): 1203-1213, 2023 05 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36408618
3.
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
N Engl J Med
; 381(20): 1897-1908, 2019 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31722150
4.
Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine.
J Infect Dis
; 223(6): 1062-1072, 2021 03 29.
Artigo
Inglês
| MEDLINE | ID: mdl-32726422
5.
Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo.
Immunity
; 28(4): 521-32, 2008 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-18387832
6.
Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial.
Vaccine
; 42(10): 2695-2706, 2024 Apr 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38494412
7.
Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5.
Nat Cell Biol
; 8(5): 435-45, 2006 May.
Artigo
Inglês
| MEDLINE | ID: mdl-16622421
8.
A randomized phase 3 trial to assess the immunogenicity and safety of 3 consecutively produced lots of freeze-dried MVA-BN® vaccine in healthy adults.
Vaccine
; 41(2): 397-406, 2023 01 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36460535
9.
Sumoylation of poly(ADP-ribose) polymerase 1 inhibits its acetylation and restrains transcriptional coactivator function.
FASEB J
; 23(11): 3978-89, 2009 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-19622798
10.
A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS.
Vaccine
; 38(11): 2600-2607, 2020 03 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32057574
11.
Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial.
Vaccine
; 38(11): 2608-2619, 2020 03 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32057576
12.
Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Mol Cell Biol
; 25(16): 6964-79, 2005 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-16055710
13.
Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial.
PLoS One
; 13(4): e0195897, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29652929
14.
Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
Oncogene
; 24(23): 3810-8, 2005 May 26.
Artigo
Inglês
| MEDLINE | ID: mdl-15806172
15.
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects.
PLoS One
; 11(6): e0157335, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27327616
16.
SUMO: a regulator of gene expression and genome integrity.
Oncogene
; 23(11): 1998-2008, 2004 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-15021887
17.
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.
PLoS One
; 10(10): e0138348, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26439129
18.
Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.
PLoS One
; 10(11): e0142802, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26554703
19.
Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
Proc Natl Acad Sci U S A
; 99(5): 2872-7, 2002 Mar 05.
Artigo
Inglês
| MEDLINE | ID: mdl-11867732